The Ins and Outs of JAK Inhibitors for Psoriatic Disease

Have questions about JAK Inhibitors? Not sure how they work, what they treat, their risks, or how effective they are compared to other treatments? Listen as rheumatologist and NPF Medical Board member, Dr. Sergio Schwartzman from Weill Cornell Medical Center in NY, addresses such questions and more about the JAK-STAT pathway.

This Psound Bytes episode is provided with support from AbbVie, Amgen, Bristol Myers Squibb, and Janssen.